reported that the short isoform of CEACAM1 decreased cell migration and invasiveness of breast cancer cells by affecting the balance between matrix metalloproteinase 2/tissue inhibitor of metalloproteinase 2 and E-/N-cadherin expression (132). The gene discussed is CEACAM1; the disease is breast cancer.